Skip to main content
. 2003 Mar 18;88(6):933–936. doi: 10.1038/sj.bjc.6600839

Table 2. Associations between CYP17 genotype and female breast cancer according to BRCA2 status.

  TT TC CC
All      
 Cases, n (%) 193 (38.6) 247 (49.4) 60 (12.0)
 Controls, n (%) 156 (39.5) 173 (43.8) 66 (16.7)
 OR (95% Cl) 1.0 1.15 (0.86–1.54) 0.73 (0.49–1.11)
BRCA2 status of cases      
 999del5, n (%) 20 (36.4) 28 (50.9) 7 (12.7)
 wt, n (%) 133 (40.2) 162 (48.9) 36 (10.9)
 OR (95% Cl) 1.0 1.15 (0.62–2.13) 1.29(0.51–3.30)